Novel targeted therapies offer new hope to slow progression and improve quality of life in meaningful ways for patients with primary biliary cholangitis (PBC).
Platinum-resistant ovarian cancer (PROC) remains one of the most significant challenges in gynecologic oncology; however, novel antibody-drug conjugates (ADCs) and innovative investigational therapies are opening new avenues to improve outcomes.
Join us for a live webinar where expert faculty will provide actionable insights on improving patient identification and engagement for CAR T-cell therapy in diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL).
This conference will foster dialogue and knowledge sharing among healthcare providers, spotlighting the latest advances in managing patients with gastrointestinal disorders & chronic liver disease (CLD).
Join us for this live national webinar designed to bridge real-world patient perspectives with the latest advances in metastatic breast cancer (MBC) care.
Join us for a dynamic, live webinar where two leading GI oncology experts will break down the latest advancements in biomarker-based, first-line treatment strategies for upper gastrointestinal (GI) cancers.
Join us for a live, interactive TheraTalk session with an expert panel of nationally recognized lipid specialists as they review the latest guideline recommendations, pivotal evidence, and evolving strategies for LDL-C management.
Enhance your expertise in MASH diagnosis and management with this one-of-a-kind preceptorship. Join us for a two-part training experience that will elevate your skills and connect you with a network of liver-focused professionals. Apply today!
Current evidence-based recommendations for prescribing diabetes medications, including newer pharmacologic classes such as glucagon-like peptide-1 receptor agonists (GLP-1r) and sodium glucose co-transporter-2 inhibitors (SGLTi) medications.
Close the technology gap and improve patient outcomes , this program provides a review of the latest diabetes technologies, including continuous glucose monitors (CGMs), insulin pumps, automated insulin delivery (AID) systems, and smart insulin pens.
